AS, M., DE, H., SP, L., Z, W., JS, L., & AP, V. (2001). The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters. Gene therapy, 8(7), 568. https://doi.org/10.1038/sj.gt.3301421
Chicago Style (17th ed.) CitationAS, Majumdar, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, and Vasserot AP. "The Telomerase Reverse Transcriptase Promoter Drives Efficacious Tumor Suicide Gene Therapy While Preventing Hepatotoxicity Encountered with Constitutive Promoters." Gene Therapy 8, no. 7 (2001): 568. https://doi.org/10.1038/sj.gt.3301421.
MLA (9th ed.) CitationAS, Majumdar, et al. "The Telomerase Reverse Transcriptase Promoter Drives Efficacious Tumor Suicide Gene Therapy While Preventing Hepatotoxicity Encountered with Constitutive Promoters." Gene Therapy, vol. 8, no. 7, 2001, p. 568, https://doi.org/10.1038/sj.gt.3301421.